Solid lipid nanoparticles and nanostructured lipid carrier-based nanotherapeutics in treatment of psoriasis: a comparative study

References

• Chandra A, Ray A, Senapati S, et al. Genetic and epigenetic basis of psoriasis pathogenesis. Mol Immunol. 2015;64:313–323.
   PubMed Web of Science ®Google Scholar
• Griffiths CEM, Barker JNWN. Pathogenesis and clinical features of psoriasis. The Lancet. 2007;370:263–271.
   PubMed Web of Science ®Google Scholar
• Lin Y-K, Huang Z-R, Zhuo R-Z, et al. Combination of calcipotriol and methotrexate in nanostructured lipid carriers for topical delivery. Int J Nanomedicine. 2010;5:117–128.
   PubMed Web of Science ®Google Scholar
• Kim ST, Jang D-J, Kim JH, et al. Topical administration of cyclosporin A in a solid lipid nanoparticle formulation. Int J Pharm Sci. 2009;64:510–514.
   Google Scholar
• Austad J, Bjerke JR, Gjertsen BT, et al. Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis. J Eur Acad Drmatol Enereol. 1998;11:19–24.
   PubMed Web of Science ®Google Scholar
• Chaturvedi SP, Kumar V. A review on disease management and drug delivery aspects in psoriasis. Curr Trends Technol Sci. 2012;1:122–125.
   Google Scholar
• Rahman M, Akhter S, Ahmad J, et al. Nanomedicine-based drug targeting for psoriasis: potentials and emerging trends in nanoscale pharmacotherapy. Exp Opin Drug Deliv. 2015;12:635–652.
   PubMed Web of Science ®Google Scholar
• Souto E, Doktorovova S, Boonme P, et al. Lipid-based colloidal systems (nanoparticles, microemulsions) for drug delivery to the skin: materials and end-product formulations. J Drug Deliv Sci Technol. 2011;21:43–54.
   Web of Science ®Google Scholar
• Müller RH, Radtke M, Wissing SA, et al. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev. 2002;54:S131–S55.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Tsai P-C, Ramezanli T, et al. Polymeric nanoparticles-based topical delivery systems for the treatment of dermatological diseases. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2013;5:205–218.
   PubMed Web of Science ®Google Scholar
• Thapa RK, Yoo BK. Evaluation of the effect of tacrolimus-loaded liquid crystalline nanoparticles on psoriasis-like skin inflammation. J Dermatol Treat. 2014;25:22–25.
   PubMed Web of Science ®Google Scholar
• Bessar H, Venditti I, Benassi L, et al. Functionalized gold nanoparticles for topical delivery of methotrexate for the possible treatment of psoriasis. Colloids Surf B Biointerfaces. 2016;141:141–147.
   PubMed Web of Science ®Google Scholar
• Pinto MF, Moura CC, Nunes C, et al. A new topical formulation for psoriasis: development of methotrexate-loaded nanostructured lipid carriers. Int J Pharm. 2014;477:519–526.
   PubMed Web of Science ®Google Scholar
• Kokelj F, Torsello P, Plozzer C, et al. Calcipotriol improves the efficacy of cyclosporine in the treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol. 1998;10:143–146.
   PubMed Web of Science ®Google Scholar
• Zhou L, Yang L, Tilton S, et al. Development of a high throughput equilibrium solubility assay using miniaturized shake‐flask method in early drug discovery. J Pharm Sci. 2007;96:3052–3071.
   PubMed Web of Science ®Google Scholar
• Ranpise NS, Korabu SS, Ghodake VN, et al. Second generation lipid nanoparticles (NLC) as an oral drug carrier for delivery of lercanidipine hydrochloride. Colloids Surf B Biointerfaces. 2014;116:81–87.
   PubMed Web of Science ®Google Scholar
• Shete H, Patravale V. Long chain lipid based tamoxifen NLC. Part I: Preformulation studies, formulation development and physicochemical characterization. Int J Pharm. 2013;454:573–583.
   PubMed Web of Science ®Google Scholar
• Griffin WC. Classification of surface-active agents by” HLB”. J Soc Cosmetic Chemists. 1946;1:311–326.
   Google Scholar
• Keck CM, Baisaeng N, Durand P, et al. Oil-enriched, ultra-small nanostructured lipid carriers (usNLC): a novel delivery system based on flip–flop structure. Int J of Pharm. 2014;477:227–235.
   PubMed Web of Science ®Google Scholar
• Pardeike J, Weber S, Haber T, et al. Development of an itraconazole-loaded nanostructured lipid carrier (NLC) formulation for pulmonary application. Int J Pharm. 2011;419:329–338.
   PubMed Web of Science ®Google Scholar
• Mukherjee S, Ray S, Thakur R, et al. Solid lipid nanoparticles: a modern formulation approach in drug delivery system. Ind J Pharm Sci. 2009;71:349.
   PubMed Web of Science ®Google Scholar
• Jain S, Mittal A, K Jain A, et al. Enhanced topical delivery of cyclosporin-A using PLGA nanoparticles as carrier. Curr Nanosci. 2011;7:524–530.
   Web of Science ®Google Scholar
• Chen J, Chen H, Cui S, et al. Glucosamine derivative modified nanostructured lipid carriers for targeted tumor delivery. J Mater Chem. 2012;22:5770–5783.
   Web of Science ®Google Scholar
• Fry DW, White JC, Goldman ID, et al. Rapid separation of low molecular weight solutes from liposomes without dilution. Anal Biochem. 1978;90:809–815.
   PubMed Web of Science ®Google Scholar
• Raza K, Singh B, Lohan S, et al. Nano-lipoidal carriers of tretinoin with enhanced percutaneous absorption, photostability, biocompatibility and anti-psoriatic activity. Int J Pharm. 2013;456:65–72.
   PubMed Web of Science ®Google Scholar
• Feng X, Tang Y, Duan X, et al. Lipid-modified conjugated polymer nanoparticles for cell imaging and transfection. J Mater Chem. 2010;20:1312–1316.
   Web of Science ®Google Scholar
• Harde H, Agrawal AK, Katariya M, et al. Development of a topical adapalene-solid lipid nanoparticle loaded gel with enhanced efficacy and improved skin tolerability. RSC Adv. 2015;5:43917–43929.
   Web of Science ®Google Scholar
• Harde H, Das M, Jain S, et al. Solid lipid nanoparticles: an oral bioavailability enhancer vehicle. Exp Opin Drug Deliv. 2011;8:1407–1424.
   PubMed Web of Science ®Google Scholar
• Jain S, Mistry MA, Swarnakar NK, et al. Enhanced dermal delivery of acyclovir using solid lipid nanoparticles. Drug Deliv Transl Res. 2011;1:395–406.
   PubMed Web of Science ®Google Scholar
• Baroli B, López-Quintela MA, Delgado-Charro MB, et al. Microemulsions for topical delivery of 8-methoxsalen. J Control Release. 2000;69:209–218.
   PubMed Web of Science ®Google Scholar
• Touitou E, Meidan VM, Horwitz E. Methods for quantitative determination of drug localized in the skin. J Control Release. 1998;56:7–21.
   PubMed Web of Science ®Google Scholar
• Surber C, Schwarb FP, Smith EW, et al. Tape-stripping technique. J Toxicol Cutan Ocul Toxicol. 2001;20:461–474.
   Web of Science ®Google Scholar
• Egbaria K, Weiner N. Liposomes as a topical drug delivery system. Adv Drug Deliv Rev. 1990;5:287–300.
   Google Scholar
• Alvarez-Román R, Naik A, Kalia Y, et al. Skin penetration and distribution of polymeric nanoparticles. J Control Release. 2004;99:53–62.
   PubMed Web of Science ®Google Scholar
• Breitkreutz D, Boukamp P, Ryle CM, et al. Epidermal morphogenesis and keratin expression in c-Ha-ras-transfected tumorigenic clones of the human HaCaT cell line. Cancer Res. 1991;51:4402–4409.
   PubMed Web of Science ®Google Scholar
• Rückert R, Asadullah K, Seifert M, et al. Inhibition of keratinocyte apoptosis by IL-15: a new parameter in the pathogenesis of psoriasis? J Immunol. 2000;165:2240–2250.
   PubMed Web of Science ®Google Scholar
• Patil-Gadhe A, Kyadarkunte A, Patole M, et al. Montelukast-loaded nanostructured lipid carriers: part II pulmonary drug delivery and in vitro–in vivo aerosol performance. Eur Jpharmaceut Biopharmaceut. 2014;88:169–177.
   PubMed Web of Science ®Google Scholar
• Gokce EH, Korkmaz E, Dellera E, et al. Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications. Int J Nanomed. 2012;7:1841.
   PubMed Web of Science ®Google Scholar
• Cao Y, Sun Z, Liao L, et al. Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo. Biochem Biophys Res Commun. 2005;332:370–379.
   PubMed Web of Science ®Google Scholar
• Koelsch C. Edible water vapor barriers: properties and promise. Trends Food Scitech. 1994;5:76–81.
   Web of Science ®Google Scholar
• Mehnert W, Mäder K. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev. 2001;47:165–196.
   PubMed Web of Science ®Google Scholar
• Schwarz C, Mehnert W, Lucks J, et al. Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization. J Control Release. 1994;30:83–96.
   Web of Science ®Google Scholar
• Severino P, Andreani T, Macedo AS, et al. Current state-of-art and new trends on lipid nanoparticles (SLN and NLC) for oral drug delivery. J Drug Deliv. 2011;2012.
   PubMedGoogle Scholar
• Testerman T, Gerster J, Imbertson L, et al. Cytokine induction by the immunomodulators imiquimod and S-27609. J Leukoc Biol. 1995;58:365–372.
   PubMed Web of Science ®Google Scholar
• Jain AK, Thanki K, Jain S, et al. Solidified self-nanoemulsifying formulation for oral delivery of combinatorial therapeutic regimen: part I. Formulation development, statistical optimization, and in vitro characterization. Pharma Res. 2014;31:923–945.
   Web of Science ®Google Scholar
• Aungst BJ, Rogers NJ, Shefter E, et al. Enhancement of naloxone penetration through human skin in vitro using fatty acids, fatty alcohols, surfactants, sulfoxides and amides. Int J Pharm. 1986;33:225–234.
   Web of Science ®Google Scholar
• Tan ES-T, Oon HH-B. Effective treatment of severe nail psoriasis using topical calcipotriol with betamethasone dipropionate gel. Indian J Dermatol Venereol Leprol. 2016;82:345.
   PubMed Web of Science ®Google Scholar
• Puglia C, Bonina F. Lipid nanoparticles as novel delivery systems for cosmetics and dermal pharmaceuticals. Exp Opin Drug Deliv. 2012;9:429–441.
   PubMed Web of Science ®Google Scholar
• Beutner KR, Tyring S. Human papillomavirus and human disease. ‎Am J Med. 1997;102:9–15.
   PubMedGoogle Scholar
• Flutter B, Nestle FO. TLRs to cytokines: mechanistic insights from the imiquimod mouse model of psoriasis. Eur J Immunol. 2013;43:3138–3146.
   PubMed Web of Science ®Google Scholar